comparemela.com
Home
Live Updates
FluoGuide releases positive interim result of FG001-CT002, a phase IIa trial evaluating FG001 in patients with non-small cell lung cancer (NSCLC) undergoing surgery : comparemela.com
FluoGuide releases positive interim result of FG001-CT002, a phase IIa trial evaluating FG001 in patients with non-small cell lung cancer (NSCLC) undergoing surgery
Copenhagen, Denmark, 6 November 2022 - FluoGuide A/S is pleased to announce that FG001 lights up in 5 out of 7 patients in an interim evaluation in the ongoing phase IIa trial in non-small cell lung... | November 6, 2022
Related Keywords
Sweden
,
Denmark
,
Copenhagen
,
Køavn
,
Fluoguideas Fluoguide
,
Morten Albrechtsen
,
European Union Horizon
,
University Hospital
,
National Lung Screening Trial Research Team
,
Department Of Cardiothoracic Surgery
,
Cardiothoracic Surgery
,
Abuse Regulation
,
Nasdaq First North Sweden
,
Cancer Statistics
,
Mortality Worldwide
,
National Lung Screening Trial Research
,
Reduced Lung Cancer Mortality
,
Low Dose Computed Tomographic
,
Fluoguideas Stock Exchange
,
News
,
Information
,
Press Release
,
,
November
,
022
,
Fluoguide
,
Us
,
Pleased
,
O
,
Nnounce
,
Hat
,
Sng001
,
Tights
,
P
,
N
,
Nut
,
F
,
Patients
,
Interim
,
Evaluation
,
The
,
Ngoing
,
Hase
,
Cia
,
Trial
,
Ell Fluo Dk0061123312
,
comparemela.com © 2020. All Rights Reserved.